ADAMTS13 and COVID-19: (2) The present study demonstrates for the first time, that generation of antibodies against ADAMTS13 is a frequent and unique finding in COVID-19 occurring in approximately one third of hospitalized patients and is associated with a lower ADAMTS13 activity suggesting an inhibitory effect on the protease.